Democratizing hedge fund level analysis tools for everyone
| Name | Penta Valent Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| PT. Tancorp Mega Buana | 80.0 | 80.0 |
| Public < 5% | 18.4 | 18.4 |
| Franxiscus Afat Adinata Nursalim | 1.6 | 1.6 |
| Lukas Rusli | 0.0 | 0.0 |
| Hermanto Tanoko | 0.0 | 0.0 |
| Treasury Shares | 0.0 | 0.0 |
| Sukismo | 0.0 | 0.0 |
| Source | 2022 | 2021 |
|---|---|---|
| 2821 | PEVE | F2 |
| 2822 | PEVE | F2 |
| 2823 | PEVE | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1676 | PEVE | F2 |
| 1677 | PEVE | F2 |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.16 | # 2 / 15 |
| EV_EBITDA | 9.42 | # 8 / 15 |
| PER | 9.66 | # 6 / 15 |
| PBV | 1.53 | # 10 / 15 |
| DER | 1.12 | # 10 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 1.6924237020985802 | # 9 / 15 |
| ROA % | 4.3 | # 9 / 15 |
| ROE % | 15.82 | # 4 / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2026 | 0.0 | 0.0 |
| 2025 | 0.0 | 0.0 |
| 2024 | 0.0 | 0.0 |
| 2023 | 0.0 | 0.0 |
| 2022 | 0.0 | 0.0 |
| 2021 | 0.0 | 0.0 |
| 2020 | 0.0 | 0.0 |
| 2019 | 0.0 | 0.0 |
| Timeframe | Performance |
|---|---|
| 1W % | 1.2 |
| 1Mo % | 7.6 |
| 3Mo % | -15.0 |
| 1Yr % | -11.5 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 9.63 | 36.98 T | 32.98 T | 38,958 B | 5,365 B | 3,839 B |
| SOHO | 20.50 | 15.29 T | 14.58 T | 10,725 B | 980 B | 746 B |
| TSPC | 8.24 | 12.76 T | 8.61 T | 14,220 B | 1,885 B | 1,550 B |
| SIDO | 16.01 | 10.68 T | 10.21 T | 2,933 B | 959 B | 667 B |
| MDLA | 6.59 | 2.91 T | 2.75 T | 16,342 B | 643 B | 442 B |
| KAEF | 123.99 | 2.56 T | 8.59 T | 9,403 B | 627 B | 21 B |